Figure 4From: Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels Percent of Medicare chronic dialysis patients with RBC transfusion, base case population stratified by year. Back to article page